EuPRAXIA Doctoral Network (EuPRAXIA-DN)
Several tens of thousands of particle accelerators are in use today with varied applications in research, industry, medicine and other fields . Yet accelerator usage could be much more widespread, were it not limited by cost and size constraints, especially in hospitals, universities and small and medium size companies. This would enable ground-breaking applications and innovations on a much larger scale.
A possible solution to this bottleneck is the development of more compact – and consequently more cost-efficient – accelerator technologies, a strategy that has been investigated in the past two decades bringing forth plasma accelerators as one of its most promising candidates.
Expected impact of EuPRAXIA on different fields.
EuPRAXIA is the first European project that develops a dedicated particle accelerator research infrastructure based on novel plasma acceleration concepts and laser technology. It focuses on the development of electron accelerators and underlying technologies, their user communities, and the exploitation of existing accelerator infrastructures in Europe. It was accepted onto the ESFRI roadmap for strategically important research infrastructures in June 2021 as a European priority.
To fully exploit the potential of this breakthrough facility, advances are urgently required in plasma and laser R&D, studies into facility design and optimization, along a coordinated push for novel applications. EuPRAXIA-DN is a new MSCA Doctoral Network for a cohort of 12 Fellows (10 Fellows will be funded from the HE-MSCA-DN funds, while 2 Fellows will be funded by the UKRI guarantee funds) between universities, research centers and industry that will carry out an interdisciplinary and cross-sector plasma accelerator research and training program for this new research infrastructure. The network focuses on scientific and technical innovations and on boosting the career prospects of its Fellows.